BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 38791331)

  • 1. Dopamine Pharmacodynamics: New Insights.
    Lauretani F; Giallauria F; Testa C; Zinni C; Lorenzi B; Zucchini I; Salvi M; Napoli R; Maggio MG
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic plasticity and addiction: learning mechanisms gone awry.
    Mameli M; Lüscher C
    Neuropharmacology; 2011 Dec; 61(7):1052-9. PubMed ID: 21277315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio.
    Papathanou M; Creed M; Dorst MC; Bimpisidis Z; Dumas S; Pettersson H; Bellone C; Silberberg G; Lüscher C; Wallén-Mackenzie Å
    Front Neural Circuits; 2018; 12():64. PubMed ID: 30210305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control.
    Speranza L; di Porzio U; Viggiano D; de Donato A; Volpicelli F
    Cells; 2021 Mar; 10(4):. PubMed ID: 33810328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine and glutamate on synaptic plasticity: a computational modeling approach for drug abuse as comorbidity in mood disorders.
    Qi Z; Kikuchi S; Tretter F; Voit EO
    Pharmacopsychiatry; 2011 May; 44 Suppl 1():S62-75. PubMed ID: 21544747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuse.
    Buck SA; Torregrossa MM; Logan RW; Freyberg Z
    FEBS J; 2021 Mar; 288(5):1462-1474. PubMed ID: 32702182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GIRK Channel Plasticity and Implications for Drug Addiction.
    Marron Fernandez de Velasco E; McCall N; Wickman K
    Int Rev Neurobiol; 2015; 123():201-38. PubMed ID: 26422986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel and Selective Dopamine Transporter Inhibitor,
    Kouhnavardi S; Ecevitoglu A; Dragačević V; Sanna F; Arias-Sandoval E; Kalaba P; Kirchhofer M; Lubec J; Niello M; Holy M; Zehl M; Pillwein M; Wackerlig J; Murau R; Mohrmann A; Beard KR; Sitte HH; Urban E; Sagheddu C; Pistis M; Plasenzotti R; Salamone JD; Langer T; Lubec G; Monje FJ
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychostimulants, madness, memory... and RGS proteins?
    Burchett SA
    Neuromolecular Med; 2005; 7(1-2):101-27. PubMed ID: 16052041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use.
    Di Chiara G
    J Psychopharmacol; 1998; 12(1):54-67. PubMed ID: 9584969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine signaling in reward-related behaviors.
    Baik JH
    Front Neural Circuits; 2013; 7():152. PubMed ID: 24130517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential vulnerabilities of neuronal reward, risk, and decision mechanisms to addictive drugs.
    Schultz W
    Neuron; 2011 Feb; 69(4):603-17. PubMed ID: 21338874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat.
    Pascual M; Boix J; Felipo V; Guerri C
    J Neurochem; 2009 Feb; 108(4):920-31. PubMed ID: 19077056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate.
    Pulvirenti L; Diana M
    Rev Neurosci; 2001; 12(2):141-58. PubMed ID: 11392455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Evoked Synaptic Plasticity of Excitatory Transmission in the Ventral Tegmental Area.
    Bellone C; Loureiro M; Lüscher C
    Cold Spring Harb Perspect Med; 2021 Apr; 11(4):. PubMed ID: 32341062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and addiction: what have we learned from 40 years of research.
    Solinas M; Belujon P; Fernagut PO; Jaber M; Thiriet N
    J Neural Transm (Vienna); 2019 Apr; 126(4):481-516. PubMed ID: 30569209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward.
    Liu X; Li Y; Yu L; Vickstrom CR; Liu QS
    Neuropsychopharmacology; 2018 Apr; 43(5):1066-1077. PubMed ID: 29039413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasticity of addiction: a mesolimbic dopamine short-circuit?
    Niehaus JL; Cruz-Bermudez ND; Kauer JA
    Am J Addict; 2009; 18(4):259-71. PubMed ID: 19444729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction.
    Thomas MJ; Kalivas PW; Shaham Y
    Br J Pharmacol; 2008 May; 154(2):327-42. PubMed ID: 18345022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurobiology of drug addiction.
    Koob GF; Nestler EJ
    J Neuropsychiatry Clin Neurosci; 1997; 9(3):482-97. PubMed ID: 9276849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.